On May 10th, the SIRUP - Stretta in Reflux Uncontrolled by PPI - study, which is sponsored by the French Government, began patient enrollment at the University Hospital in Nantes, France. The SIRUP study is a multi-center (Bordeaux, Lyon, Rouen, Nantes), double blinded, randomized, sham-controlled study of patients who continue to have GERD symptoms while on PPI medications. Up to 40% of the population of GERD sufferers fall into this category and have few options to achieve symptom relief or a normal quality of life. Patients interested in participating in the study should contact Mederi Therapeutics for more information. Will Rutan, ...Read More »

The 13th Annual Conference of the Society of Gastrointestinal Endoscopy of India  (SGEI), Endocon 2012, in Kolkata India, featured live procedures of minimally invasive therapies, Secca for Bowel Control Disorder and Stretta for GERD. Both procedures were performed by Dr. Mark Noar, Director of Endoscopic Microsurgery Associates and the Bowel Control Disorder Center in Towson, Maryland. The conference was held April 26-29, 2012 and consisted of academic symposia, as well as live procedures performed at Apollo Gleneagles Hospital. The agenda was constructed based on membership feedback, which showed Secca and Stretta to be therapies of high interest to this physician ...Read More »

Ohio Society of Gastrointestinal Nurses Association (OSGNA) Newsletter Spring 2012 Contributor: Richard Barthelmes, RN, BSN, CGRN, Endoscopy Nurse at The OSU Hospitals. Reprinted with permission What does "Stretta" mean to you, especially if you have been around endoscopy for a while? Maybe nothing. Maybe you think of loading bags of sterile water into a refrigerator, or giving enough sedation to rival a complicated ERCP. But if you have memories, you recall a dwindling supply of disposable probes, then no probes at all. Eventually the Stretta generator was pushed into a corner of your unit, and finally, the equipment boneyard. Then one day ...Read More »

As many as 20 million young American women may be silently suffering from a debilitating disorder that few have heard of and even fewer admit to; that disorder is BCD, or Bowel Control Disorder. Although the prevalence of bowel control disorder and the extent of its impact on quality of life are drastically under-reported, there are several significant facts about it that are known.  Chief among them are that BCD can be a severely debilitating condition, and that it overwhelmingly targets women—particularly women who have had children.  What’s unknown is exactly how many women are affected.  The commonly accepted estimate in ...Read More »

Gao, Wang, et al, evaluated 505 patients with GERD-related RSs, such as cough, wheezing, and hoarseness. These patients were diagnosed and then treated with the Stretta procedure. Symptom scores were compared pre- and post- operatively, via the Reflux Disease Diagnostic Questionnaire (RDQ) 15 and all decreased significantly at the end of the follow-up period. Only minor complications were reported. The study results were published in the Chinese Medical Journal. • Mean heartburn score decreased from 5.31 to 1.79 (P Read More »

Visit Mederi at 23rd Annual International Colorectal Disease Symposium & 33rd Annual Turnbull Symposium, in Fort Lauderdale, February 14-19 2012 Mederi will be showcasing both Secca Therapy for BCD and Stretta Therapy for GERD at next week's combo Symposium - Booth 10. The Symposium agenda includes sessions on Options for the Management of Fecal Incontinence, a presentation on patient selection for Secca Therapy, by Professor Roman Herman from University of Krakow, Poland, and a talk on the Costs of Anal Incontinence, by Dr. Marvin Corman from Stonybrook University in New York. We hope to see you there! Sheila Doyle Mederi, MarketingRead More »

A Secca Procedure Workshop was held February 7, at University College London Hospital. The workshop was well attended by 30 delegates from the UK: Exeter, Bristol, Edinburgh, Southend, London, Birmingham, Peterborough, Cardiff, Sheffield, Reading, Doncaster, Canterbury and Liverpool and from abroad: Germany, Lebannon, Switzerland, and Italy. The workshop consisted of three live Secca cases, as well as academic presentations by a distinguished faculty. The faculties for this event were: Mr. C. Richard Cohen, MD FRCS Consultant Colorectal Surgeon; Mr. Alastair C. J. Windsor MD FRCS FRCS(Ed), Consultant Colorectal Surgeon; Mr. Dave Chatoor, Pelvic Floor Research Fellow in Colorectal Surgery, Course Director; ...Read More »

Mederi Adds Twitter to Social Media Footprint Follow Mederi on Twitter @MederiNews. Keep up to date with the latest information on Secca Therapy and Stretta Therapy and the disease states they treat. If you're interested in the conditions GERD and Bowel Control Disorder, their prevalence and treatment options, follow Mederi. Add to the conversation and search for information using these hashtags: #seccatherapy #strettatherapy #GERD #BCD Thanks for continuing the conversation with us. Sheila Doyle Mederi, Marketing Read More »

INDICATIONS FOR USE: The Stretta System is intended for general use in electrosurgical coagulation of tissue and intended for use specifically in the treatment of gastroesophageal reflux disease (GERD). CONTRAINDICATIONS: There are no known absolute contraindications to the use of radiofrequency in humans. The use of the Stretta System is contraindicated when, in the judgment of the physician, radiofrequency surgical procedures would be contrary to the best interests of the patient. The following is a list of patient groups in whom the use of the Stretta System for the treatment of GERD may be contraindicated: Subjects under the age of 18; ...Read More »

INDICATIONS FOR USE: The Secca System is intended for the treatment of fecal incontinence in those patients with incontinence to solid or liquid stool at least once per week and who have failed more conservative therapy. CONTRAINDICATIONS: There are no known absolute contraindications to the use of radiofrequency in humans. The use of electrosurgery is contraindicated when, in the judgment of the physician, electrosurgical procedures would be contrary to the best interest of the patient. The following may be considered contraindications specific to this procedure: Crohn’s disease or ulcerative colitis (inflammatory bowel disease); Collagen vascular disease (Raynaud’s, Systemic Sclerosis); History of ...Read More »